Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
View Full Paper
Ask AI
Bookmark
Share
Discussion
Loading...
Member takes
Implication
Key Points
Key points are not available for this paper at this time.